+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication (Cancer, Wound Care, Diabetes), and Region - Forecast to 2027

  • PDF Icon

    Report

  • 324 Pages
  • November 2022
  • Region: Global
  • Markets and Markets
  • ID: 5178506

Increased Preference for Personalized Care

The global home healthcare market is projected to reach USD 340.2 Billion by 2027 from USD 226.0 Billion in 2022, at a CAGR of 8.5% during the forecast period Growth in this market is mainly driven by the technological advancements in home healthcare products and services.

The therapeutic products segment accounted for the highest growth rate in the home healthcare market, by product, during the forecast period

The home healthcare market is segmented into testing, screening, and monitoring products; therapeutic products; and mobility care products based on product. In 2021, the therapeutic products segment accounted for the highest growth rate in the home healthcare market. Market growth can largely be attributed to growing prevalence of chronic diseases.

Infusion therapy services segment accounted for the highest CAGR

Based on the services, the home healthcare market has been segmented into skilled nursing services, rehabilitation therapy services, hospice & palliative care services, unskilled care services, respiratory therapy services, infusion therapy services, and pregnancy care services. In 2021, the skilled nursing services segment accounted for the highest growth rate. This can be attributed to the rising population and urbanization.

Asia Pacific: The fastest-growing region home healthcare market

The global home healthcare market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Factors such as initiatives by government to promote home healthcare, and higher healthcare costs.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and the Middle East & Africa - 4%

Lists of Companies Profiled in the Report:

  • Fresenius SE & Co. KGaA (Germany)
  • Linde, Plc (Ireland)
  • F.Hoffmann-La Roche, Ltd. (Switzerland)
  • A&D Company, Limited (Japan)
  • Bayada Home Health Care (US)
  • Invacare Corporation (US)
  • Abbott (US)
  • Amedisys (US)
  • ResMed, Inc. (US)
  • LHC Group, Inc. (US)
  • Omron Corporation (Japan)
  • Koninkluke Philips N.V. (Netherlands)
  • GE Healthcare (US)
  • Drive Devilbiss Healthcare (UK)
  • Hamilton Medical (Switzerland)
  • Sunrise Medical (Germany)
  • Roma Medical (UK)
  • Caremax Rehabilitation Equipment Co., Ltd. (China)
  • Vitalograph (UK)
  • Advita Pflegedienst Gmbh (Germany)
  • Renafan Gmbh (Germany)
  • ADMR (France)
  • Apex Medical Corp. (Taiwan)
  • Contec Medical Systems Co., Ltd. (China)
  • Löwenstein Medical Technology Gmbh + Co., KG. (Germany)
  • B. Braun Melsungen Ag (Germany)
  • Baxter International, Inc. (US)
  • Allied Healthcare Products, Inc. (US)
  • Medline Industries, Inc. (US)
  • Advin Health Care (India)

Research Coverage:

This report provides a detailed picture of the global home healthcare market. It aims at estimating the size and future growth potential of the market across different segments, such as product, service, indication, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall home healthcare market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

Frequently Asked Questions about the Global Home Healthcare Market

What is the estimated value of the Global Home Healthcare Market?

The Global Home Healthcare Market was estimated to be valued at $226 Billion in 2022.

What is the growth rate of the Global Home Healthcare Market?

The growth rate of the Global Home Healthcare Market is 8.5%, with an estimated value of $340.2 Billion by 2027.

What is the forecasted size of the Global Home Healthcare Market?

The Global Home Healthcare Market is estimated to be worth $340.2 Billion by 2027.

Who are the key companies in the Global Home Healthcare Market?

Key companies in the Global Home Healthcare Market include Fresenius SE & Co. KGaA (Germany), Linde, Plc (Ireland), F.Hoffmann, La Roche, Ltd. (Switzerland), A&D Company, Limited (Japan), Bayada Home Health Care (US), Invacare Corporation (US), Abbott (US), Amedisys (US) and ResMed, Inc. (US).

Table of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
Table 1 Inclusions and Exclusions
1.3 Study Scope
1.4 Years Considered
1.5 Currency Considered
1.6 Stakeholders
1.7 Summary of Changes
1.8 Limitations

2 Research Methodology
2.1 Research Data
Figure 1 Home Healthcare Market: Research Design Methodology
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
Table 2 Key Data from Primary Sources
Figure 2 Key Industry Insights
2.1.2.1 Breakdown of Primary Interviews
Figure 3 Breakdown of Primary Interviews: Supply-Side and Demand-Side Participants (Home Healthcare Market)
Figure 4 Breakdown of Primary Interviews: by Company Type, Designation, and Region
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
Figure 5 Bottom-Up Approach: Company Revenue Estimation Approach
Figure 6 Revenue Share Analysis Illustration: F. Hoffmann-La Roche Ltd.
2.2.1.1 Growth Forecast
2.2.1.2 CAGR Projections
Figure 7 CAGR Projections: Supply-Side Analysis
2.2.2 Top-Down Approach
Figure 8 Home Healthcare Market: Top-Down Approach
2.3 Market Breakdown and Data Triangulation
Figure 9 Data Triangulation Methodology
2.4 Market Share Analysis
2.5 Study Assumptions
2.6 Risk Assessment

3 Executive Summary
Figure 10 Home Healthcare Market, by Type, 2022 Vs. 2027 (USD Billion)
Figure 11 Home Healthcare Market, by Product, 2022 Vs. 2027 (USD Billion)
Figure 12 Home Healthcare Market, by Service, 2022 Vs. 2027 (USD Billion)
Figure 13 Home Healthcare Market, by Indication, 2022 Vs. 2027 (USD Billion)
Figure 14 Geographical Snapshot of Home Healthcare Market

4 Premium Insights
4.1 Home Healthcare Market Overview
Figure 15 Growing Target Patient Population to Drive Market Growth During the Forecast Period
4.2 Asia-Pacific: Home Healthcare Market, by Product (2021)
Figure 16 Therapeutic Products Accounted for Largest Market Share
4.3 Geographic Growth Opportunities in Home Healthcare Market
Figure 17 Japan and China to Register Highest Growth During Forecast Period
4.4 Home Healthcare Market: Geographic Mix
Figure 18 APAC to Witness Highest Growth During Forecast Period
4.5 Home Healthcare Market: Developed Vs. Emerging Economies
Figure 19 Developing Markets to Register Higher Growth

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 20 Home Healthcare Market: Drivers, Restraints, Opportunities, and Challenges
5.2.1 Drivers
5.2.1.1 Rapid Growth in Elderly Population and Rising Incidence of Chronic Diseases
Table 3 Geriatric Population, 2022 Vs. 2050 (Million)
5.2.1.2 Rising R&D Investments
Table 4 Product Launches
5.2.1.3 Growing Need for Cost-Effective Healthcare Delivery due to Rising Costs
5.2.1.4 Increased Preference for Personalized Care
5.2.2 Restraints
5.2.2.1 Changing Reimbursement Policies
5.2.2.2 Limited Insurance Coverage
5.2.2.3 Patient Safety Concerns
5.2.3 Opportunities
5.2.3.1 Rising Focus on Telehealth
5.2.3.2 Untapped Developing Regions
5.2.3.3 Growing Demand for Home-Use Therapeutic Devices
5.2.3.4 Growing Demand for Home Sleep Apnea Tests
5.2.3.5 Rising Preference for Home Hemodialysis Treatment
5.2.4 Challenges
5.2.4.1 Shortage of Home Care Workers
5.2.4.2 Lack of Supporting Infrastructure
5.3 Pricing Analysis
Table 5 Average Selling Price of Products Offered by Key Players (2022)
Table 6 Average Selling Price of Home Healthcare Products (2022)
5.4 Patent Analysis
5.4.1 Patent Analysis for Temperature Monitoring Devices
5.4.1.1 Granted Patent Publication Trends for Temperature Monitoring Devices
Figure 21 Patent Publication Trends (January 2012-December 2021)
5.4.1.2 Insights: Jurisdiction and Top Applicant Analysis
Figure 22 Top Patent Applicants & Owners (Companies/Institutions) for Temperature Monitoring Devices (January 2012-December 2021)
Figure 23 Top Patent Applicant Countries/Regions for Temperature Monitoring Devices (January 2012-December 2021)
Figure 24 Patent Analysis for Thermometers (January 2012-December 2021)
5.4.2 List of Key Patents
5.5 Value Chain Analysis
Figure 25 Value Chain Analysis: Major Value Added During Manufacturing and Assembly Phases
5.6 Supply Chain Analysis
Figure 26 Home Healthcare Market: Supply Chain Analysis
5.7 Ecosystem/Market Map
Figure 27 Home Healthcare Market: Ecosystem/Market Map
5.7.1 Home Healthcare Market: Role in Ecosystem
5.8 Porter's Five Forces Analysis
5.8.1 Pulse Oximeters
Table 7 Porter's Five Forces Analysis for the Pulse Oximeters Market
5.8.1.1 Threat of New Entrants
5.8.1.2 Threat of Substitutes
5.8.1.3 Bargaining Power of Suppliers
5.8.1.4 Bargaining Power of Buyers
5.8.1.5 Degree of Competition
5.8.2 Hearing Aids
Table 8 Porter's Five Forces Analysis: Hearing Aids Market
5.8.2.1 Threat of New Entrants
5.8.2.2 Threat of Substitutes
5.8.2.3 Bargaining Power of Buyers
5.8.2.4 Bargaining Power of Suppliers
5.8.2.5 Degree of Competition
5.9 Regulatory Landscape
Table 9 North America: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 10 Europe: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 11 Asia-Pacific: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 12 Latin America: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 13 RoW: List of Regulatory Bodies, Government Agencies, and Other Organizations
5.9.1 North America
5.9.1.1 US
Table 14 Us Fda: Classification of Medical Devices
Table 15 US: Medical Device Regulatory Approval Process
Figure 28 Premarket Notification: 510(K) Approvals for Medical Devices
5.9.1.2 Canada
Table 16 Canada: Medical Device Regulatory Approval Process
Figure 29 Approval Process for Medical Devices in Canada
5.9.2 Europe
Figure 30 Ce Approval Process in Europe for Medical Devices
5.9.3 Asia-Pacific
5.9.3.1 Japan
Table 17 Japan: Classification of Medical Devices and Reviewing Bodies
5.9.3.2 China
Table 18 China: Classification of Medical Devices
5.9.3.3 India
5.1 Trade Analysis
5.10.1 Trade Analysis for Blood Pressure Monitors
Table 19 Import Data for Blood Pressure Monitors, by Country, 2017-2021 (USD Million)
Table 20 Export Data for Blood Pressure Monitors, by Country, 2017-2021 (USD Million)
5.11 Technology Analysis
5.12 Key Conferences & Events in 2022-2023
Table 21 Home Healthcare Market: Conferences & Events
5.13 Trends/Disruptions Impacting Customers’ Businesses
Figure 31 Revenue Shift in Home Healthcare
5.14 Key Stakeholders & Buying Criteria
5.14.1 Key Stakeholders in Buying Process
Figure 32 Influence of Stakeholders on Buying Process of Home Healthcare Products
Table 22 Influence of Stakeholders on Buying Process of Home Healthcare Products
5.14.2 Buying Criteria
Figure 33 Key Buying Criteria for Home Healthcare Products
Table 23 Key Buying Criteria for Home Healthcare Products

6 Home Healthcare Market, by Product
6.1 Introduction
Table 24 Home Healthcare Market, by Product, 2020-2027 (USD Billion)
6.2 Therapeutic Products
Table 25 Key Therapeutic Products Offered
Table 26 Therapeutic Products Market, by Type, 2020-2027 (USD Billion)
Table 27 Therapeutic Products Market, by Region, 2020-2027 (USD Billion)
6.2.1 Dialysis Equipment
6.2.1.1 Dialysis Equipment to Hold Largest Market Share
Table 28 Dialysis Equipment Market, by Region, 2020-2027 (USD Million)
6.2.2 Wound Care Products
6.2.2.1 Decreased Costs and Higher Convenience and Comfort to Drive Market Growth
Table 29 Wound Care Products Market, by Region, 2020-2027 (USD Million)
6.2.3 Iv Equipment
6.2.3.1 Accuracy and Growing Target Disease Prevalence to Ensure Market Growth
Table 30 Iv Equipment Market, by Region, 2020-2027 (USD Million)
6.2.4 Sleep Apnea Therapeutic Devices
6.2.4.1 Increasing Patient Preference for Home-Based Sleep Tests to Fuel Market
Table 31 Sleep Apnea Therapeutic Devices Market, by Region, 2020-2027 (USD Million)
6.2.5 Insulin Delivery Devices
6.2.5.1 High Incidence of Diabetes to Drive Market
Table 32 Insulin Delivery Devices Market, by Region, 2020-2027 (USD Million)
6.2.6 Oxygen Delivery Systems
6.2.6.1 Technological Advancements in Oxygen Therapy Products to Drive Market
Table 33 Oxygen Delivery Systems Market, by Region, 2020-2027 (USD Million)
6.2.7 Inhalers
6.2.7.1 High Incidence of Asthma to Boost Market
Table 34 Inhalers Market, by Region, 2020-2027 (USD Million)
6.2.8 Nebulizers
6.2.8.1 Effectiveness Over Oral Dosages to Push Preference for Nebulizers
Table 35 Nebulizers Market, by Region, 2020-2027 (USD Million)
6.2.9 Ventilators
6.2.9.1 Convenience and Comfort to Sustain End-User Preference
Table 36 Ventilators Market, by Region, 2020-2027 (USD Million)
6.2.10 Other Therapeutic Products
Table 37 Other Therapeutic Products, by Region, 2020-2027 (USD Million)
6.3 Testing, Screening, and Monitoring Products
Table 38 Key Testing, Screening, and Monitoring Products Offered
Table 39 Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 40 Testing, Screening, and Monitoring Products Market, by Region, 2020-2027 (USD Million)
6.3.1 Blood Glucose Monitors
6.3.1.1 Increasing Prevalence of Diabetes to Drive Market Growth
Table 41 Blood Glucose Monitors Market, by Region, 2020-2027 (USD Million)
6.3.2 Hearing Aids
6.3.2.1 High Incidence of Hearing Impairment to Drive Market
Table 42 Hearing Aids Market, by Region, 2020-2027 (USD Million)
6.3.3 Activity Monitors & Wristbands
6.3.3.1 Increasing Prevalence of Chronic Diseases to Bolster Demand for Activity Monitors
Table 43 Activity Monitors & Wristbands Market, by Region, 2020-2027 (USD Million)
6.3.4 Blood Pressure Monitors
6.3.4.1 Rising Patient Population for Hypertension and Cvd to Drive Market
Table 44 Blood Pressure Monitors Market, by Region, 2020-2027 (USD Million)
6.3.5 Ecg/Ekg Devices
6.3.5.1 High Prevalence of Cvd to Support Demand
Table 45 Ecg/Ekg Devices Market, by Region, 2020-2027 (USD Million)
6.3.6 Temperature Monitoring Devices
6.3.6.1 Technological Innovations and Increasing Awareness to Drive Growth
Table 46 Temperature Monitoring Devices Market, by Region, 2020-2027 (USD Million)
6.3.7 Heart Rate Monitors
6.3.7.1 Continuous Cardiac Parameter Monitoring Capabilities to Drive Demand
Table 47 Heart Rate Monitors Market, by Region, 2020-2027 (USD Million)
6.3.8 Ovulation & Pregnancy Test Kits
6.3.8.1 Privacy, Convenience, Accessibility, and Quick Results to Drive Market
Table 48 Ovulation & Pregnancy Test Kits Market, by Region, 2020-2027 (USD Million)
6.3.9 Fetal Monitoring Devices
6.3.9.1 Remote-Based Care by Portable Fetal Monitoring Systems to Drive Market Growth
Table 49 Fetal Monitoring Devices Market, by Region, 2020-2027 (USD Million)
6.3.10 Pulse Oximeters
6.3.10.1 Rising Disease Incidence and Wide Usage of Pulse Oximetry to Ensure Strong Demand
Table 50 Pulse Oximeters Market, by Region, 2020-2027 (USD Million)
6.3.11 Hiv Test Kits
6.3.11.1 Rising Prevalence of Hiv to Drive Market
Table 51 Hiv Test Kits Market, by Region, 2020-2027 (USD Million)
6.3.12 Holter & Event Monitors
6.3.12.1 Rising Awareness of Preventive Care and Technological Advancements to Drive Market
Table 52 Holter & Event Monitors Market, by Region, 2020-2027 (USD Million)
6.3.13 Drug & Alcohol Test Kits
6.3.13.1 Rising Consumption of Drugs Among Teens to Support Market Growth
Table 53 Drug & Alcohol Test Kits Market, by Region, 2020-2027 (USD Million)
6.3.14 Coagulation Monitoring Products
6.3.14.1 Rising Use of Anticoagulant Therapy and Availability of Home-Use Kits to Drive Market
Table 54 Coagulation Monitoring Products Market, by Region, 2020-2027 (USD Million)
6.3.15 Peak Flow Meters
6.3.15.1 High Portability and Cost-Efficiency to Ensure Adoption
Table 55 Peak Flow Meters Market, by Region, 2020-2027 (USD Million)
6.3.16 Colon Cancer Test Kits
6.3.16.1 High Incidence of Colorectal Cancer to Drive Market Growth
Table 56 Colon Cancer Test Kits Market, by Region, 2020-2027 (USD Million)
6.3.17 Home Sleep Testing Devices
6.3.17.1 Cost-Effectiveness of Home-Based Sleep Tests to Fuel Growth
Table 57 Home Sleep Testing Devices Market, by Region, 2020-2027 (USD Million)
6.3.18 Eeg Devices
6.3.18.1 Wide Patient Population for Epilepsy to Drive Market for Eeg Devices
Table 58 Eeg Devices Market, by Region, 2020-2027 (USD Million)
6.3.19 Cholesterol Testing Products
6.3.19.1 Rising Obesity Levels and Cvd Incidence to Support Market
Table 59 Cholesterol Testing Products Market, by Region, 2020-2027 (USD Million)
6.3.20 Home Hemoglobin A1C Test Kits
6.3.20.1 High Incidence of Diabetes to Drive Market
Table 60 Home Hemoglobin A1C Test Kits Market, by Region, 2020-2027 (USD Million)
6.4 Mobility Care Products
Table 61 Key Mobility Care Products Available in the Market
Table 62 Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 63 Mobility Care Products Market, by Region, 2020-2027 (USD Million)
6.4.1 Wheelchairs
6.4.1.1 Increased Preference for Wheelchairs to Boost Demand
Table 64 Wheelchairs Market, by Region, 2020-2027 (USD Million)
6.4.2 Mobility Scooters
6.4.2.1 High Cost to Affect End-User Adoption
Table 65 Mobility Scooters Market, by Region, 2020-2027 (USD Million)
6.4.3 Walkers & Rollators
6.4.3.1 Difficulties in Using Walkers and Availability of Alternatives to Restrain Market
Table 66 Walkers & Rollators Market, by Region, 2020-2027 (USD Million)
6.4.4 Crutches
6.4.4.1 High Preference for Axilla Crutches to Support Demand
Table 67 Crutches Market, by Region, 2020-2027 (USD Million)
6.4.5 Canes
6.4.5.1 Wide Usage of Canes to Drive Market
Table 68 Canes Market, by Region, 2020-2027 (USD Million)

7 Home Healthcare Market, by Service
7.1 Introduction
Table 69 Home Healthcare Market, by Service, 2020-2027 (USD Billion)
Table 70 Home Healthcare Services Market, by Region, 2020-2027 (USD Billion)
7.2 Skilled Nursing Services
7.2.1 Skilled Nursing Services to Dominate Market
Table 71 Skilled Nursing Services Market, by Region, 2020-2027 (USD Million)
7.3 Rehabilitation Therapy Services
7.3.1 Rising Demand, Growing Geriatric Population, and Increasing Disease Incidence to Boost Demand for Therapy
Table 72 Rehabilitation Therapy Services Market, by Region, 2020-2027 (USD Million)
7.4 Hospice & Palliative Care Services
7.4.1 Rising Geriatric Population to Drive Hospice & Palliative Care Service Demand
Table 73 Hospice & Palliative Care Services Market, by Region, 2020-2027 (USD Million)
7.5 Unskilled Care Services
7.5.1 Cost-Effectiveness to Drive Growth
Table 74 Unskilled Services Market, by Region, 2020-2027 (USD Million)
7.6 Respiratory Therapy Services
7.6.1 Growing Prevalence of Respiratory Disorders to Drive Market
Table 75 Respiratory Therapy Services Market, by Region, 2020-2027 (USD Million)
7.7 Infusion Therapy Services
7.7.1 Safety and Effectiveness of Home Infusion to Drive Demand
Table 76 Infusion Therapy Services Market, by Region, 2020-2027 (USD Million)
7.8 Pregnancy Care Services
7.8.1 Need for Better Management of High-Risk Pregnancies and Complications to Ensure Market Growth
Table 77 Pregnancy Care Market, by Region, 2020-2027 (USD Million)

8 Home Healthcare Market, by Indication
8.1 Introduction
Table 78 Home Healthcare Market, by Indication, 2020-2027 (USD Billion)
Table 79 Home Healthcare Indications Market, by Region, 2020-2027 (USD Billion)
8.2 Cancer
8.2.1 Cancer to Dominate Indications Market
Table 80 Incidence of Cancer, by Region, 2020 Vs. 2030 Vs. 2040 (Million)
Table 81 Home Healthcare Market for Cancer, by Region, 2020-2027 (USD Million)
8.3 Respiratory Diseases
8.3.1 Rising Prevalence of Respiratory Diseases to Drive Market
Table 82 Home Healthcare Market for Respiratory Diseases, by Region, 2020-2027 (USD Million)
8.4 Movement Disorders
8.4.1 Growing Geriatric Population to Drive Demand for Therapy Equipment
Table 83 Home Healthcare Market for Movement Disorders, by Region, 2020-2027 (USD Million)
8.5 Cvd & Hypertension
8.5.1 Rising Incidence of Hypertension & Cardiovascular Diseases to Drive Growth
Table 84 Home Healthcare Market for Cvd & Hypertension, by Region, 2020-2027 (USD Million)
8.6 Pregnancy
8.6.1 Rising Focus on Better Care & Monitoring During Pregnancy to Drive Market Growth
Table 85 Home Healthcare Market for Pregnancy, by Region, 2020-2027 (USD Million)
8.7 Wound Care
8.7.1 Growing Number of Road Accidents and Trauma Injuries to Drive Market Growth
Table 86 Home Healthcare Market for Wound Care, by Region, 2020-2027 (USD Million)
8.8 Diabetes
8.8.1 Increasing Incidence of Diabetes to Propel Market Growth
Table 87 Home Healthcare Market for Diabetes, by Region, 2020-2027 (USD Million)
8.9 Hearing Disorders
8.9.1 Worldwide Increase in Hearing Disabilities to Ensure Sustained Growth
Table 88 Home Healthcare Market for Hearing Disorders, by Region, 2020-2027 (USD Million)
8.10 Other Indications
Table 89 Home Healthcare Market for Other Indications, by Region, 2020-2027 (USD Million)

9 Home Healthcare Market, by Region
9.1 Introduction
Table 90 Home Healthcare Market, by Region, 2020-2027 (USD Billion)
9.2 North America
Figure 34 North America: Home Healthcare Market Snapshot
Table 91 North America: Home Healthcare Market, by Country, 2020-2027 (USD Billion)
Table 92 North America: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 93 North America: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 94 North America: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 95 North America: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 96 North America: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 97 North America: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 98 North America: Home Healthcare Market, by Indication, 2020-2027 (USD Million)
9.2.1 US
9.2.1.1 Us to Dominate North American Home Healthcare Market
Table 99 US: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 100 US: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 101 US: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 102 US: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 103 US: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 104 US: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 105 US: Home Healthcare Market, by Indication, 2020-2027 (USD Million)
9.2.2 Canada
9.2.2.1 Rising Geriatric Population to Drive Market Growth
Table 106 Canada: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 107 Canada: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 108 Canada: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 109 Canada: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 110 Canada: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 111 Canada: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 112 Canada: Home Healthcare Market, by Indication, 2020-2027 (USD Million)
9.3 Europe
Table 113 Europe: Home Healthcare Market, by Country, 2020-2027 (USD Billion)
Table 114 Europe: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 115 Europe: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 116 Europe: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 117 Europe: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 118 Europe: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 119 Europe: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 120 Europe: Home Healthcare Market, by Indication, 2020-2027 (USD Million)
9.3.1 Germany
9.3.1.1 Germany to Retain Market Leadership in Europe
Table 121 Germany: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 122 Germany: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 123 Germany: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 124 Germany: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 125 Germany: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 126 Germany: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 127 Germany: Home Healthcare Market, by Indication, 2020-2027 (USD Million)
9.3.2 UK
9.3.2.1 Rising Burden of Chronic Diseases to Boost Market Growth
Table 128 UK: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 129 UK: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 130 UK: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 131 UK: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 132 UK: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 133 UK: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 134 UK: Home Healthcare Market, by Indication, 2020-2027 (USD Million)
9.3.3 France
9.3.3.1 Government Support and Initiatives Taken by Market Players to Boost Market
Table 135 France: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 136 France: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 137 France: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 138 France: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 139 France: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 140 France: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 141 France: Home Healthcare Market, by Indication, 2020-2027 (USD Million)
9.3.4 Italy
9.3.4.1 Rising Geriatric Population and Favorable Government Policy to Drive Market Growth
Table 142 Italy: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 143 Italy: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 144 Italy: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 145 Italy: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 146 Italy: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 147 Italy: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 148 Italy: Home Healthcare Market, by Indication, 2020-2027 (USD Million)
9.3.5 Spain
9.3.5.1 Rising Geriatric Population and Incidence of Chronic Conditions to Drive Market Growth
Table 149 Spain: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 150 Spain: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 151 Spain: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 152 Spain: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 153 Spain: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 154 Spain: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 155 Spain: Home Healthcare Market, by Indication, 2020-2027 (USD Million)
9.3.6 Rest of Europe
Table 156 Roe: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 157 Roe: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 158 Roe: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 159 Roe: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 160 Roe: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 161 Roe: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 162 Roe: Home Healthcare Market, by Indication, 2020-2027 (USD Million)
9.4 Asia-Pacific
Figure 35 APAC: Home Healthcare Market Snapshot
Table 163 Asia-Pacific: Home Healthcare Market, by Country, 2020-2027 (USD Billion)
Table 164 Asia-Pacific: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 165 Asia-Pacific: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 166 Asia-Pacific: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 167 Asia-Pacific: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 168 Asia-Pacific: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 169 Asia-Pacific: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 170 Asia-Pacific: Home Healthcare Market, by Indication, 2020-2027 (USD Million)
9.4.1 Japan
9.4.1.1 Japan to Command Largest Share of APAC Market
Table 171 Japan: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 172 Japan: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 173 Japan: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 174 Japan: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 175 Japan: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 176 Japan: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 177 Japan: Home Healthcare Market, by Indication, 2020-2027 (USD Million)
9.4.2 China
9.4.2.1 Healthcare Development and Reforms to Drive Market Growth
Table 178 China: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 179 China: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 180 China: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 181 China: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 182 China: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 183 China: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 184 China: Home Healthcare Market, by Indication, 2020-2027 (USD Million)
9.4.3 India
9.4.3.1 Increasing Target Patient Population to Drive Market
Table 185 India: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 186 India: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 187 India: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 188 India: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 189 India: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 190 India: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 191 India: Home Healthcare Market, by Indication, 2020-2027 (USD Million)
9.4.4 Rest of Asia-Pacific
Table 192 Roapac: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 193 Roapac: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 194 Roapac: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 195 Roapac: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 196 Roapac: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 197 Roapac: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 198 Roapac: Home Healthcare Market, by Indication, 2020-2027 (USD Million)
9.5 Rest of the World
Table 199 RoW: Home Healthcare Market, by Product & Service, 2020-2027 (USD Billion)
Table 200 RoW: Home Healthcare Market, by Product, 2020-2027 (USD Million)
Table 201 RoW: Therapeutic Products Market, by Type, 2020-2027 (USD Million)
Table 202 RoW: Testing, Screening, and Monitoring Products Market, by Type, 2020-2027 (USD Million)
Table 203 RoW: Mobility Care Products Market, by Type, 2020-2027 (USD Million)
Table 204 RoW: Home Healthcare Market, by Service, 2020-2027 (USD Million)
Table 205 RoW: Home Healthcare Market, by Indication, 2020-2027 (USD Million)

10 Competitive Landscape
10.1 Overview
10.2 Key Strategies Adopted by Players/Right to Win
Table 206 Overview of Strategies Deployed by Key Companies
10.3 Revenue Share Analysis of Top Market Players
Figure 36 Revenue Share Analysis of Top Players
10.4 Market Share Analysis
Figure 37 Sleep Apnea Therapeutic Devices Market Share Analysis, by Key Player (2021)
Figure 38 Blood Glucose Monitors Market Share Analysis, by Key Player (2021)
10.5 Company Evaluation Quadrant (2021)
10.5.1 Stars
10.5.2 Emerging Leaders
10.5.3 Pervasive Players
10.5.4 Participants
Figure 39 Home Healthcare Market: Company Evaluation Quadrant, 2021
10.6 Company Evaluation Quadrant for Start-Ups/Smes (2021)
10.6.1 Progressive Companies
10.6.2 Starting Blocks
10.6.3 Responsive Companies
10.6.4 Dynamic Companies
Figure 40 Home Healthcare Market: Company Evaluation Quadrant for Start-Ups/Smes, 2021
10.7 Competitive Benchmarking
Figure 41 Product and Regional Footprint Analysis of Top Players
Table 207 Home Healthcare Market: Competitive Benchmarking of Key Players
Table 208 Product Footprint of Key Players
Table 209 Regional Footprint of Key Players
Table 210 Home Healthcare Market: Detailed List of Key Start-Ups/Smes
10.8 Competitive Scenario
10.8.1 Product Launches
Table 211 Key Product Launches & Regulatory Approvals
10.8.2 Deals
Table 212 Key Deals
10.8.3 Other Developments
Table 213 Other Key Developments, January 2019-October 2022

11 Company Profiles
(Business Overview, Products Offered, Recent Developments, and Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 Key Players
11.1.1 Fresenius
Table 214 Fresenius: Business Overview
Figure 42 Fresenius: Company Snapshot (2021)
Table 215 Fresenius: Exchange Rates Utilized for Conversion of Eur to Usd
Table 216 Fresenius: Product Launches
Table 217 Fresenius: Deals
Table 218 Fresenius: Other Developments
11.1.2 Linde
Table 219 Linde: Business Overview
Figure 43 Linde: Company Snapshot (2021)
11.1.3 F. Hoffmann-La Roche
Table 220 F. Hoffmann-La Roche: Business Overview
Figure 44 F. Hoffmann-La Roche: Company Snapshot (2021)
Table 221 F. Hoffmann-La Roche: Exchange Rates Utilized for Conversion of Chf to USD 262
Table 222 F. Hoffmann-La Roche: Product Launches & Approvals
Table 223 F. Hoffmann-La Roche: Deals
11.1.4 A&D Company
Table 224 A&D Company: Business Overview
Figure 45 A&D Company: Company Snapshot (2022)
Table 225 A&D Company: Product Launches
11.1.5 Invacare Corporation
Table 226 Invacare Corporation: Business Overview
Figure 46 Invacare Corporation: Company Snapshot (2021)
Table 227 Invacare Corporation: Product Launches
11.1.6 Abbott
Table 228 Abbott: Business Overview
Figure 47 Abbott: Company Snapshot (2021)
Table 229 Abbott: Product Launches and Product Approvals
Table 230 Abbott: Deals
11.1.7 Amedisys
Table 231 Amedisys: Business Overview
Figure 48 Amedisys: Company Snapshot (2021)
Table 232 Amedisys: Deals
11.1.8 Resmed
Table 233 Resmed: Business Overview
Figure 49 Resmed: Company Snapshot (2022)
Table 234 Resmed: Deals
11.1.9 Lhc Group
Table 235 Lhc Group: Business Overview
Figure 50 Lhc Group: Company Snapshot (2021)
Table 236 Lhc Group: Deals
11.1.10 Omron Corporation
Table 237 Omron Corporation: Business Overview
Figure 51 Omron Corporation: Company Snapshot (2022)
Table 238 Omron Corporation: Exchange Rates Utilized for Conversion of Yen to USD 292
Table 239 Omron Corporation: Deals
11.1.11 Koninklijke Philips
Table 240 Koninklijke Philips: Business Overview
Figure 52 Koninklijke Philips: Company Snapshot (2021)
Table 241 Koninklijke Philips: Exchange Rates Utilized for Conversion of Eur to USD 297
Table 242 Koninklijke Philips: Product/Service Launches and Approvals
Table 243 Koninklijke Philips: Deals
11.1.12 GE Healthcare
Table 244 GE Healthcare: Business Overview
Figure 53 GE Healthcare: Company Snapshot (2022)
Table 245 GE Healthcare: Deals
11.2 Other Players
11.2.1 Bayada Home Health Care
11.2.2 Drive Devilbiss Healthcare Limited
11.2.3 Hamilton Medical
11.2.4 Sunrise Medical
11.2.5 Roma Medical
11.2.6 Caremax Rehabilitation Equipment
11.2.7 Vitalograph
11.2.8 Advita Pflegedienst
11.2.9 Renafan GmbH
11.2.10 Admr
11.2.11 Apex Medical Corp.
11.2.12 Contec Medical Systems
11.2.13 Löwenstein Medical Technology
11.2.14 B. Braun Melsungen Ag
11.2.15 Baxter International
11.2.16 Allied Healthcare Products
11.2.17 Medline Industries
11.2.18 Advin Health Care

*Details on Business Overview, Products Offered, Recent Developments, and Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) Might Not be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Discussion Guide
12.2 Knowledgestore: The Subscription Portal
12.3 Customization Options

Executive Summary

Companies Mentioned

  • Fresenius SE & Co. KGaA (Germany)
  • Linde, Plc (Ireland)
  • F.Hoffmann-La Roche, Ltd. (Switzerland)
  • A&D Company, Limited (Japan)
  • Bayada Home Health Care (US)
  • Invacare Corporation (US)
  • Abbott (US)
  • Amedisys (US)
  • ResMed, Inc. (US)
  • LHC Group, Inc. (US)
  • Omron Corporation (Japan)
  • Koninkluke Philips N.V. (Netherlands)
  • GE Healthcare (US)
  • Drive Devilbiss Healthcare (UK)
  • Hamilton Medical (Switzerland)
  • Sunrise Medical (Germany)
  • Roma Medical (UK)
  • Caremax Rehabilitation Equipment Co., Ltd. (China)
  • Vitalograph (UK)
  • Advita Pflegedienst Gmbh (Germany)
  • Renafan Gmbh (Germany)
  • ADMR (France)
  • Apex Medical Corp. (Taiwan)
  • Contec Medical Systems Co., Ltd. (China)
  • Löwenstein Medical Technology Gmbh + Co., KG. (Germany)
  • B. Braun Melsungen Ag (Germany)
  • Baxter International, Inc. (US)
  • Allied Healthcare Products, Inc. (US)
  • Medline Industries, Inc. (US)
  • Advin Health Care (India)

Methodology

Loading
LOADING...